Allergy

Latest News

May 30th 2025

Chronic Allergic Inflammation's Impact on Brain Chemistry and Mood: Gary Falcetano, PA-C, AE-C

By Cameron Santoro
Gary Falcetano, PA-C, AE-C

May 22nd 2025

Chronic Urticaria Linked to Specific Gut Bacteria and Metabolic Pathways

By Cameron Santoro

May 10th 2025

Pediatric Food Allergy Diagnosis Could Be Streamlined By New Scoring System

By Cameron Santoro

May 6th 2025

Rilzabrutinib Reduces Itch and Hives in Antihistamine-Resistant Chronic Spontaneous Urticaria

By Cameron Santoro

May 2nd 2025

National Asthma and Allergy Awareness Month: Economic Costs, Threats to Access, and the Impact of Policy Changes

By Cameron Santoro

Video Interviews

View All

May 29th 2025

Exploring the Interplay of Spring Allergies, Inflammation, and Mental Health: Gary Falcetano, PA-C, AE-C

August 20th 2024

Patient Education, Provider Education, and Overall Final Thoughts

August 13th 2024

Navigating New Frontiers: Bruton Tyrosine Kinase Inhibitors in Chronic Spontaneous Urticaria Treatment

August 13th 2024

The Evaluation of Dupilumab In Chronic Spontaneous Urticaria Treatment

August 6th 2024

Key Updates Needed in Chronic Spontaneous Urticaria Guidelines

August 6th 2024

Addressing Persistent Symptoms in Chronic Spontaneous Urticaria: Beyond IgE-Targeted Treatments

July 29th 2024

The Use of Systemic Corticosteroids In Chronic Spontaneous Urticaria Treatment

July 29th 2024

Approaches to Switching Between Antihistamines and Other Medications When Treating Patients with Chronic Spontaneous Urticaria 

July 29th 2024

Therapies Typically Used in the Firstline For Patients With Chronic Spontaneous Urticaria 

July 29th 2024

Healthcare Specialties Involved in Managing Patients With Chronic Spontaneous Urticaria 

More News

Dupilumab. | Image Credit: Semi - stock.adobe.com

Published: April 29th 2025 | Updated: April 29th 2025

Dupilumab Treatment for Patients With CSU: Insights From Jason Hawkes, MD, MS

Maddi Hebebrand

Jason Hawkes, MD, MS, provided an in-depth look at the potential role of dupilumab (Dupixent; Sanofi and Regeneron Pharmaceuticals) in the management of chronic spontaneous urticaria (CSU), a condition with limited therapeutic options over the past decade.

Urticaria allergy. | Image Credit: Alex Pios - stock.adobe.com

April 23rd 2025

Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions

Cameron Santoro

Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.

FDA Approved. | Image Credit: Tada Images - stock.adobe.com

April 18th 2025

FDA Greenlights Dupilumab for Chronic Spontaneous Urticaria, Marking First Approval in a Decade

Cameron Santoro

Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose hives and itching remain uncontrolled by antihistamines.

Skin hives. | Image Credit: Алексей Филатов - stock.adobe.com

April 16th 2025

Complete Responses Seen With Emerging Therapies for Chronic Spontaneous Urticaria

Cameron Santoro

There have been new developments in treatments for chronic spontaneous urticaria, with several options showing complete response in patients, particularly among those who are difficult to treat.

Hives, allergy. | Image Credit: Tanapat Lek,jew - stock.adobe.com

April 15th 2025

Significant Disease Burden and Management Issues in Chronic Spontaneous Urticaria

Cameron Santoro

Patients with chronic spontaneous urticaria experienced a long delay in diagnosis, a substantial impact on their quality of life, and often received inadequate treatment, highlighting the need for better management and understanding of the condition.

glass like gene strands | Image Credit: Сергей Шиманович - stock.adobe.com

April 5th 2025

Safety and Efficacy Updates for Asthma and Urticaria Therapies

Cameron Santoro

The long-term safety and efficacy of treatments for allergy and inflammatory conditions was highlighted at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization Joint Congress.

Child with allergies outside with a tissue | Image credit: pingpao - stock.adobe.com

April 3rd 2025

Genetics and Environment Both Play a Role in Childhood Allergy Progression

Chelsie Derman

Genetics and environment both influence allergy risk, but environmental factors play a stronger role in the progression of allergic disease.

Child scratching neck on a yellow background | Image credit: Pixel-Shot - stock.adobe.com

April 2nd 2025

Oral Immunotherapy Can Play Key Role in Food Allergy Management in Preschool-Aged Patients

Gillian McGovern

Further research is needed to clarify the cost-effectiveness, long-term adherence, and psychosocial impacts of oral immunotherapy.

A panel of 4 experts on chronic spontaneous urticaria

July 12th 2024

Differential Diagnosis When Considering Chronic Spontaneous Urticaria 

Brian Keegan, MD, PhD Giselle Mosnaim, MD Stanley Goldstein, MD Anitha Shrikhande, MD, MPH

Stanley Goldstein, MD, discusses the differential diagnosis when considering CSU.

July 12th 2024

The Epidemiology Associated With Chronic Spontaneous Urticaria 

Brian Keegan, MD, PhD Giselle Mosnaim, MD Stanley Goldstein, MD Anitha Shrikhande, MD, MPH

Giselle Mosnaim, MD, discusses the epidemiology that is associated with CSU.

June 28th 2024

Hallmark Symptoms of Chronic Spontaneous Urticaria

Brian Keegan, MD, PhD Giselle Mosnaim, MD Stanley Goldstein, MD Anitha Shrikhande, MD, MPH

Experts on chronic spontaneous urticaria outline the hallmark symptoms most associated with the disease and how they fluctuate with time.

June 28th 2024

The Pathophysiology of Chronic Spontaneous Urticaria

Brian Keegan, MD, PhD Giselle Mosnaim, MD Stanley Goldstein, MD Anitha Shrikhande, MD, MPH

A panel of experts describe the pathophysiology of chronic spontaneous urticaria.

June 14th 2024

Newer Treatments for CSU Show Fast Response, Says Dr Gil Yosipovitch

AJMC Staff

Data on new treatments for chronic spontaneous urticaria (CSU) show significant symptom reduction very early during treatment.

June 7th 2024

Dr Gil Yosipovitch: Biologics Have Changed the World of CSU Care

AJMC Staff

Given the lack of efficacy of antihistamines for most patients with chronic spontaneous urticaria (CSU), biologics have changed the entire world of CSU.

May 24th 2024

Patients With CSU Need New Therapies, Says Dr Jonathan Bernstein

AJMC Staff

While there is treatment for chronic spontaneous urticaria (CSU), there remains a need for newer therapies, explained allergy specialist Jonathan Bernstein, MD.

May 17th 2024

CSU Can Affect All Aspects of Patients’ Lives, Explained Dr Jonathan Bernstein

AJMC Staff

The chronic nature of the hives affecting patients with chronic spontaneous urticaria (CSU) can really affect all aspects of their lives, including sleep, daily activities, work, and interpersonal relationships.

May 10th 2024

Chronic and Unpredictable: The Anxiety of Living With CSU

AJMC Staff

The chronic and unpredictable nature of chronic spontaneous urticaria (CSU) can cause crippling anxiety around how long the painful symptoms of the disease will last, explained Kristen Willard, a patient advocate with CSU.

May 3rd 2024

The Challenging Diagnosis and Long Treatment Journey of CSU, From a Patient Perspective

AJMC Staff

The pain of chronic spontaneous urticaria (CSU) can be crippling, explained Kristen Willard, a patient advocate with CSU, who discussed her treatment journey.

1 2 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions